…
Do Humiras declining sales give Abbott Laboratories the edge as the better growth stock?…
Do Humiras declining sales give Abbott Laboratories the edge as the better growth stock?…
Der US-Pharmakonzern Abbott Laboratories (ISIN: US0028241000, NYSE: ABT) wird seine Quartalsdividende um 7,8 Prozent auf nun 55 US-Cents je Aktie…
Todays Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT)…
Leading immunoprotein diagnostic testing market players include Thermofisher Scientific Inc., Abbott Laboratories, Abcam plc, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin…
The Global Melanoma Therapeutics Market Size was valued at USD 5.03 Billion in 2022 and the Worldwide Melanoma Therapeutics Market…
The Global Biotechnology Instruments Market Size was valued at USD 69.7 Billion in 2022 and the Worldwide Biotechnology Instruments Market…
…
The Molecular Quality Controls Market was valued at USD 195.64 Million in 2022. The Global molecular quality controls market is…
Companies covered in this study are Terumo Corp, Abbott Laboratories, Boston Scientific Corp, Asahi Intecc Co Ltd, Cardinal Health, Cook…
Key blood screening market players include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho al Diagnostics,…
CODE Zuletzt zahlten Investoren für das Wertpapier 102,38 US-Dollar. Kaum auffällig ist zur Stunde an der Börse der Kurs von…
…
The Global Legionella Testing Market Size was valued at USD 292.40 Million in 2022 and the Worldwide Legionella Testing Market…
New medicines for weight loss and diabetes stand to disrupt the competitive scene.…
The Global Immunoassay Market Size was valued at USD 32.45 Billion in 2022 and the Global immunoassay market Size is…
Deep Brain Stimulation Devices Companies Analyzed are Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc.,…
Major lateral flow assays (LFA) market players include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La…
Wenig Kursbewegung gegenwärtig bei der Abbott Laboratories-Aktie . Das Wertpapier kostete zuletzt 94,78 US-Dollar. Kaum auffällig ist zur Stunde an…
…
Abbott Laboratories is getting into the consumer wearables market.…
Abbott Laboratories is getting into the consumer wearables market.…
ABT earnings call for the period ending September 30, 2023.…
…
Trotz eines leichten Umsatzrückgangs im dritten Quartal erhöht Abbott Laboratories die Prognose für 2023. An der Börse kommt das gut…
Die Aktie von Abbott Laboratories zählt heute zu den großen Gewinnern am Aktienmarkt. Das Papier verteuert sich am Mittwoch deutlich.…
Abbott Laboratories shares ABT climbed 2.5% premarket on Wednesday after the healthcare products company posted a better-than-expected third-quarter profit and…
Abbott Laboratories on Wednesday tightened its profit forecast for the year after beating estimates for third-quarter earnings due to strong…
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Neurostimulation Devices - Global Market Insights, Competitive Landscape, and Market…
Dont just focus on the recent past.…
Leading drug delivery devices market players include Antares Pharma, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Johnson…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten der Citigroup bewerten die Aktie von Abbott Laboratories (ISIN: US0028241000, WKN: 850103, Ticker-Symbol: ABL,…
[228 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global…
New York (www.aktiencheck.de) - Abbott Laboratories-Aktienanalyse von Analyst Matthew Taylor von Jefferies & Co:
Matthew Taylor, Analyst von Jefferies & Co,…
Leading Oncology Active Pharmaceutical Ingredient (API) Market players include Sanofi, AbbVie Inc., Merck & Co. Inc., Pfizer Inc., Abbott Laboratories,…
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Peripheral Nerve Repair Devices Market (2023-2028) by Product Type,…
Zürich/Frankfurt (Reuters) - Wiederaufgeflammte Übernahmespekulationen haben die Aktien der Schweizer Biotechnologiefirma Actelion auf ein Rekordhoch gehoben.
Vertreter von Europas größtem…